Cargando…
Dabigatran Excess: Case Report and Review of the Literature
INTRODUCTION: Novel oral anticoagulants are increasingly used for stroke prophylaxis in patients with non-valvular atrial fibrillation. While these agents offer a more predictable pharmacokinetic profile, the lack of readily available laboratory tests to monitor the level of anticoagulation and abse...
Autores principales: | Sarma, Amy, Rossi, Jeffrey E., Connors, Jean M., Giugliano, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107435/ https://www.ncbi.nlm.nih.gov/pubmed/25135294 http://dx.doi.org/10.1007/s40119-013-0016-1 |
Ejemplares similares
-
Thrombocytopenia induced by dabigatran: two case reports
por: Kang, Hyun Goo, et al.
Publicado: (2017) -
Dabigatran-etexilate: Lack of efficacy: case report
Publicado: (2021) -
Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021) -
Cardiac Sarcoidosis: Case Report, Workup, and Review of the Literature
por: Plitt, Anna, et al.
Publicado: (2013) -
Renal infarction in a patient with thyrotoxicosis‐induced atrial fibrillation treated successfully with dabigatran, a case report and literature review
por: Al‐sadi, Anas, et al.
Publicado: (2022)